404 related articles for article (PubMed ID: 21671538)
21. US panel narrows recommendations for low dose aspirin for cardiovascular disease prevention.
McCarthy M
BMJ; 2015 Sep; 351():h4991. PubMed ID: 26392600
[No Abstract] [Full Text] [Related]
22. Aspirin resistance: is it real? Is it clinically significant?
Dalen JE
Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
[No Abstract] [Full Text] [Related]
23. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
24. Aspirin for primary prevention of cardiovascular disease?
Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
[TBL] [Abstract][Full Text] [Related]
25. Aspirin for primary prevention of cardiovascular disease (revisited).
Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
[No Abstract] [Full Text] [Related]
26. Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study.
Welin L; Wilhelmsen L; Björnberg A; Odén A
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1143-9. PubMed ID: 19672841
[TBL] [Abstract][Full Text] [Related]
27. [Primary cardiovascular prevention with aspirin].
Seguí Díaz M; Escobar C; Divisón JA
Semergen; 2015; 41(5):279-81. PubMed ID: 25622997
[No Abstract] [Full Text] [Related]
28. Update on aspirin. People with heart disease should take aspirin; the decision is trickier for those without it.
Harv Heart Lett; 2011 Aug; 21(12):3. PubMed ID: 21991607
[No Abstract] [Full Text] [Related]
29. [The role of aspirin in the primary prevention of cardiovascular disease].
Rodondi N; Cornuz J
Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
[TBL] [Abstract][Full Text] [Related]
30. [A 100 years of aspirin: a drug with a future?].
Sánchez García P
An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
[No Abstract] [Full Text] [Related]
31. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
32. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.
De Caterina R
Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774
[TBL] [Abstract][Full Text] [Related]
33. Aspirin and gastrointestinal toxicity.
Törüner M
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
[TBL] [Abstract][Full Text] [Related]
34. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
Wynn RL
Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
[No Abstract] [Full Text] [Related]
35. [Aspirin and primary prevention of cardiovascular diseases in the elderly].
Manríquez M; Vallano A
Rev Esp Geriatr Gerontol; 2009; 44(6):349-51. PubMed ID: 19726108
[No Abstract] [Full Text] [Related]
36. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
37. [Aspirin for primary cardiovascular disease prevention - an update].
De Caterina R
G Ital Cardiol (Rome); 2017 Jan; 18(1):1-6. PubMed ID: 28287208
[No Abstract] [Full Text] [Related]
38. Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice.
Mora S; Ames JM; Manson JE
JAMA; 2016 Aug; 316(7):709-10. PubMed ID: 27323335
[No Abstract] [Full Text] [Related]
39. Aspirin for prevention of myocardial infarction.
Mirvis DM
J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
[No Abstract] [Full Text] [Related]
40. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
Hobson A; Curzen N
Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
